Literature DB >> 24293538

Stage 3 pyomyositis of the gluteus minimus; Staphylococcus aureus sepsis, autoanticoagulation, proximal femoral osteomyelitis and the role of surgical intervention.

Peter Jonathan Dacombe1, Jennifer Evans, Oliver Burton Gosling, James Heal.   

Abstract

Primary pyomyositis is a rare bacterial infection of the skeletal muscle. Traditionally a tropical disease, it is increasingly described in westernised urban populations. The aetiology is due to transient bacteraemia in the presence of risk factors such as traumatised muscle, or immunocompromise. The condition presents in one of three stages, representing progression of disease severity. Intravenous antibiotic therapy is often sufficient for this disease at its early stage, but surgical drainage is necessary for advanced presentations. We report a severe case of stage 3 pyomyositis of the gluteus minimus, which led to Staphylococcus aureus sepsis, deranged liver function, acute kidney injury, autoanticoagulation and proximal femoral osteomyelitis in a healthy 64-year-old Caucasian man. This illustrates the potential severity of the disease, the life-threatening sequelae when diagnosis is delayed and the role of surgical drainage in averting the progression of systemic sepsis to end-organ dysfunction, disseminated intravascular coagulation and potentially death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293538      PMCID: PMC3847639          DOI: 10.1136/bcr-2013-201357

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Pyomyositis in children.

Authors:  A J Gubbay; D Isaacs
Journal:  Pediatr Infect Dis J       Date:  2000-10       Impact factor: 2.129

Review 2.  Primary pyomyositis.

Authors:  J Bickels; L Ben-Sira; A Kessler; S Wientroub
Journal:  J Bone Joint Surg Am       Date:  2002-12       Impact factor: 5.284

3.  Nontropical pyomyositis: analysis of eight patients in an urban center.

Authors:  A Hossain; E D Reis; K Soundararajan; M D Kerstein; L H Hollier
Journal:  Am Surg       Date:  2000-11       Impact factor: 0.688

4.  Infection of the psoas muscle secondary to Streptococcus pneumoniae infection.

Authors:  J L Steiner; E J Septimus; C V Vartian
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

5.  Obturator internus muscle abscess in a child: a case report.

Authors:  Manish Bansal; Vijay Bhaliak; Colin E Bruce
Journal:  J Pediatr Orthop B       Date:  2008-09       Impact factor: 1.041

Review 6.  Pyomyositis: clinical features and predisposing conditions.

Authors:  S R Patel; T P Olenginski; J L Perruquet; T M Harrington
Journal:  J Rheumatol       Date:  1997-09       Impact factor: 4.666

7.  Pyomyositis--tropical and nontropical.

Authors:  G W Geelhoed; H Gray; I A Alavi; H Lattoo
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

Review 8.  Pyomyositis in children and adolescents: report of 12 cases and review of the literature.

Authors:  D A Spiegel; J S Meyer; J P Dormans; J M Flynn; D S Drummond
Journal:  J Pediatr Orthop       Date:  1999 Mar-Apr       Impact factor: 2.324

9.  Multifocal streptococcal pyomyositis complicated by acute compartment syndrome: case report.

Authors:  P Harrington; B Scott; P Chetcuti
Journal:  J Pediatr Orthop B       Date:  2001-04       Impact factor: 1.041

Review 10.  Pyomyositis in North America: case reports and review.

Authors:  L Christin; G A Sarosi
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

View more
  2 in total

Review 1.  Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Authors:  Trisha A Rettig; Julie N Harbin; Adelaide Harrington; Leonie Dohmen; Sherry D Fleming
Journal:  Clin Immunol       Date:  2015-07-02       Impact factor: 3.969

2.  Incidence and type of meniscal tears in multilligament injured knees.

Authors:  Chloé Labarre; Seong Hwan Kim; Nicolas Pujol
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-07-19       Impact factor: 4.114

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.